SGCB and pulmonary arterial hypertension: Indeed, the capability of NO to reduce the uncontrolled proliferation of vascular smooth muscle cells that lead to the occlusion of vessels and an increase in pulmonary vascular resistances (more than a mere vasodilation) is believed to be the main mechanism of action of PD5i and sGC in PAH.